NCT06157541
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06157541
Title T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma (TCaP)
Acronym TCaP
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Queensland Institute of Medical Research
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Newro Foundation Bowen Hills Queensland 4006 Australia Details
Royal Brisbane and Women's Hospital Herston Queensland 4006 Australia Details
Princess Alexandra Hospital Woolloongabba Queensland 4102 Australia Details
Austin Hospital Heidelberg Victoria 3084 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field